Prediction model for hepatocellular carcinoma occurrence in patients with hepatitis C in the era of direct-acting anti-virals.
Yuki TahataRyotaro SakamoriRyoko YamadaTakahiro KodamaHayato HikitaHideki HagiwaraYasuharu ImaiNaoki HiramatsuShinji TamuraKeiji YamamotoMasahide OshitaKazuyoshi OhkawaTaizo HijiokaHiroyuki FukuiToshifumi ItoYoshinori DoiYukinori YamadaTakayuki YakushijinYuichi YoshidaTomohide TatsumiTetsuo Takeharanull nullPublished in: Alimentary pharmacology & therapeutics (2021)
A prediction model combining these four factors contributes to an efficient surveillance strategy for HCC occurrence after DAA-mediated SVR.
Keyphrases